Fernández Conde Sonia, Cifo Arcos Daniel, Sánchez-Cambronero Cejudo Laura, Olmedo Lucerón Carmen, Fernández Dueñas Ana, Cantero Gudino Elena, Limia Sánchez Aurora
Área de Programas de Vacunación; Ministerio de Sanidad. Madrid. España.
Escuela Nacional de Sanidad; Instituto de Salud Carlos III. Madrid. España.
Rev Esp Salud Publica. 2023 Dec 29;97:e202312116.
Four modifications were introduced in the Lifetime Vaccination Schedule of the Interterritorial Council of the National Health System (CISNS) in 2023.The aim of this study was to estimate the cost of vaccinating a healthy person and people with certain risk conditions throughout life in Spain and to compare with a previous estimation from 2019.
A descriptive study of the cost of administering the vaccines included in the Lifetime Vaccination Schedule for the year 2023 and in the schedule for risk groups was carried out.
The estimated cost to immunize a healthy person throughout life in 2023 is 1,541.56€ for a woman and 1,498.18€ for a men, which corresponds to an increase of 125% compared to the cost in 2019. The risk conditions with the highest cost are asplenia and complement deficiency and primary immunodeficiencies, with a cost of 3,159.82 euros and 2,566 euros respectively on average. The cost of vaccinating the whole healthy population in Spain in a year is around 565M€. Moreover, the cost of vaccinating the new-borns cohort of 2023 was estimated at 500M€.
Despite the cost increase in 2023, immunization is still a very cheap intervention, considering the economic impact of immunopreventable diseases in the society. The relative low cost of immunization throughout life makes this health intervention useful and worthwhile.
2023年,国家卫生系统跨地区委员会(CISNS)的终身疫苗接种计划引入了四项修改。本研究的目的是估计在西班牙为健康人和有特定风险状况的人进行一生疫苗接种的成本,并与2019年之前的估计进行比较。
对2023年终身疫苗接种计划以及风险群体计划中所含疫苗的接种成本进行了描述性研究。
2023年为一名健康女性进行一生免疫接种的估计成本为1541.56欧元,男性为1498.18欧元,与2019年的成本相比增加了125%。成本最高的风险状况是无脾症、补体缺陷和原发性免疫缺陷,平均成本分别为3159.82欧元和2566欧元。西班牙每年为全体健康人群接种疫苗的成本约为5.65亿欧元。此外,2023年新生儿队列的疫苗接种成本估计为5亿欧元。
尽管2023年成本有所增加,但考虑到免疫可预防疾病对社会的经济影响,免疫接种仍然是一种非常廉价的干预措施。一生免疫接种的相对低成本使得这种健康干预措施有用且值得。